+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lifestyle Diseases Apps Market - Global Forecast 2026-2032- Product Image
Lifestyle Diseases Apps Market - Global Forecast 2026-2032- Product Image
Sale

Lifestyle Diseases Apps Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055747
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lifestyle Diseases Apps Market is projected to reach USD 6.98 Billion in 2026. It is expected to continue growing at a CAGR of 14.85%, reaching USD 16.14 Billion by 2032.

Lifestyle Disease Apps: Executive Overview

Lifestyle disease apps support prevention, monitoring, education, and behavior change for conditions associated with factors such as physical inactivity, nutrition, tobacco use, and chronic stress. Their role is expanding as health systems seek scalable ways to complement clinical care, improve self-management, and reach people between appointments. The category includes tools for activity tracking, nutrition, weight management, medication adherence, glucose monitoring, cardiovascular risk reduction, sleep, and mental wellbeing. Value depends on clinical relevance, usability, privacy, interoperability, and sustained engagement rather than download volume alone.

Digital Care Is Shifting Toward Continuous, Integrated Prevention

The landscape is moving from standalone wellness applications toward connected services that combine patient-generated data, remote monitoring, coaching, educational content, and clinician workflows. Wearables and connected devices are making activity, sleep, heart rate, and glucose-related information more available, while digital therapeutics and virtual care models are increasing expectations for structured, evidence-informed interventions. Regulation, reimbursement, cybersecurity, accessibility, and the ability to demonstrate meaningful behavioral or clinical outcomes are becoming central competitive requirements. Personalization and frictionless onboarding are also increasingly important because long-term adherence remains difficult when applications create excessive alerts, complex tasks, or unclear benefits.

Artificial Intelligence Is Strengthening Personalization, Triage, and Engagement

Artificial intelligence can help lifestyle disease applications identify patterns in user data, tailor goals, prioritize reminders, summarize information, and support conversational education. Predictive models may assist with risk stratification and early intervention when they are trained on representative data and embedded within appropriate clinical governance. Generative systems can improve accessibility through conversational interfaces and adaptive explanations, but they also introduce risks involving inaccurate advice, automation bias, privacy, and opaque decision-making. Responsible deployment therefore requires human oversight, transparent limitations, consent management, bias testing, secure data practices, and validation against clinically meaningful outcomes.

Regional Insights: Regulation, Access, and Care Integration Shape Adoption

North America is characterized by mature digital-health infrastructure, strong consumer adoption of connected devices, and growing integration with providers and payers, alongside heightened scrutiny of privacy, evidence, and reimbursement. Europe emphasizes data protection, medical-device governance, interoperability, and public-health integration, with meaningful variation across national systems. Asia-Pacific combines advanced digital ecosystems in some markets with major opportunities to extend access through mobile-first services in others. Latin America is shaped by uneven connectivity, private-sector innovation, and the need for affordable tools that address chronic-care access gaps. The Middle East is investing in digitally enabled health transformation and prevention, while localization and workforce integration remain important. Africa presents substantial potential for mobile-based education, screening support, and self-management, but affordability, connectivity, language diversity, and continuity of care are decisive considerations.

Group Insights: Diverse Policy and Economic Blocs Require Tailored Models

ASEAN markets benefit from mobile adoption but differ substantially in health-system capacity, regulation, language, and urban-rural access, favoring modular and locally adapted services. BRICS economies represent varied disease burdens, digital infrastructures, and public-private delivery models, making interoperability and affordability especially important. The European Union places strong emphasis on privacy, cross-border data governance, digital identity, and standards-based exchange. G7 countries generally have advanced clinical and digital infrastructure, but face aging populations, fragmented care pathways, and demanding evidence expectations. GCC states are prioritizing prevention, national digital transformation, and coordinated health platforms, with localization and trust influencing uptake. NATO members span diverse health systems, yet resilience, cybersecurity, and continuity of digital services are common strategic concerns.

Country Insights: Local Health Priorities Determine Product-Market Fit

Australia and Canada must address dispersed populations, primary-care coordination, and equitable digital access. Brazil, Mexico, India, and South Africa benefit from mobile-first approaches that can extend education and monitoring, while affordability, language, and uneven clinical capacity require careful design. China, Japan, and South Korea combine strong technology capabilities with distinct regulatory, demographic, and health-system requirements. France, Germany, Italy, Spain, and the United Kingdom emphasize evidence, privacy, interoperability, and integration with established public or mixed health services. Russia’s operating environment is shaped by domestic digital infrastructure, regulatory conditions, and access considerations. In the United States, employer, payer, provider, and direct-to-consumer pathways create broad opportunity but also require attention to fragmented data, reimbursement, privacy, and clinical accountability.

Action Priorities for Leaders Building Trusted Lifestyle Disease Apps

Industry leaders should begin with a clearly defined clinical or behavioral problem and specify measurable outcomes such as adherence, validated symptom change, risk-factor improvement, or engagement sustained over time. Build privacy, cybersecurity, accessibility, multilingual support, and transparent consent into the product rather than treating them as later compliance tasks. Establish interoperability with relevant health records, devices, and care workflows, and develop evidence plans appropriate to the intended claims. Use artificial intelligence selectively, with monitoring for bias, hallucination, drift, and unsafe recommendations. Partnerships with clinicians, public-health organizations, employers, payers, and patient groups can improve relevance and distribution, while transparent pricing and low-bandwidth functionality can support more equitable adoption.

Research Methodology: Evidence-Led Assessment of the Application Landscape

This executive summary uses a structured review of the lifestyle disease application landscape, organizing findings around care delivery, user needs, enabling technologies, regulation, infrastructure, and health-system integration. Comparative interpretation considers the required regions, country groups, and individual countries, with attention to differences in epidemiology, connectivity, digital maturity, privacy regimes, reimbursement, and clinical workflow. Artificial intelligence is assessed as an enabling capability rather than a standalone market category. Conclusions are limited to qualitative, data-backed themes and do not infer market size, market share, or forecasts. Findings should be refreshed as regulatory guidance, clinical evidence, platform standards, and public-health priorities evolve.

Conclusion: Sustainable Impact Depends on Trust and Clinical Relevance

Lifestyle disease apps are becoming part of a broader prevention and chronic-care ecosystem rather than isolated consumer tools. The strongest offerings will connect useful data with understandable guidance, appropriate human support, and care pathways that users and professionals can trust. Regional and country differences make localization essential, while artificial intelligence can improve personalization only when governed responsibly. Leaders that combine evidence, interoperability, privacy, accessibility, and sustained engagement will be better positioned to deliver practical support for healthier behaviors and more continuous management of lifestyle-related disease.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Lifestyle Diseases Apps Market, by Functionality
7.1. Introduction
7.2. Clinical Decision Support
7.3. Monitoring & Follow-Up
7.4. Patient Education & Empowerment
7.5. Treatment & Medication Management
8. Lifestyle Diseases Apps Market, by Indications
8.1. Introduction
8.2. Asthma
8.3. Cardiovascular Conditions
8.4. Diabetes
8.5. Hypertension
8.6. Obesity
9. Lifestyle Diseases Apps Market, by Type
9.1. Introduction
9.2. Mobile Apps
9.2.1. Android Apps
9.2.2. iOS Apps
9.3. Web-Based Platforms
10. Lifestyle Diseases Apps Market, by User
10.1. Introduction
10.2. Healthcare Providers
10.2.1. Hospitals & Clinics
10.2.2. Rehabilitation Centers
10.3. Patients
11. Lifestyle Diseases Apps Market, by Deployment Mode
11.1. Introduction
11.2. On-cloud
11.3. On-premises
12. Lifestyle Diseases Apps Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Lifestyle Diseases Apps Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Lifestyle Diseases Apps Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Apple Inc.
16.2. BetterMe Inc.
16.3. Buoy Health, Inc.
16.4. Calm.com, Inc.
16.5. Cerebral, Inc.
16.6. ClassPass Inc.
16.7. Fitbit, Inc.
16.8. FitOn Inc.
16.9. Fooducate, Ltd.
16.10. Google LLC
16.11. Headspace Inc.
16.12. JEFIT Inc.
16.13. Johnson & Johnson
16.14. Kaiser Permanente
16.15. Kilo Health
16.16. Lark Technologies, Inc.
16.17. Lifesum AB
16.18. MapMyFitness, Inc.
16.19. Mindbody, Inc.
16.20. MyFitnessPal, Inc.
16.21. Noom, Inc.
16.22. Omada Health, Inc.
16.23. Peloton Interactive, Inc.
16.24. Samsung Electronics Co., Ltd.
16.25. Teladoc Health, Inc.
16.26. UnitedHealth Group
16.27. Virta Health Corp.
16.28. Weight Watchers International, Inc.
16.29. WW International, Inc.
16.30. Yazio GmbH
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Lifestyle Diseases Apps Market, Years Considered for the Study
FIGURE 2. Global Lifestyle Diseases Apps Market, Research Design
FIGURE 3. Global Lifestyle Diseases Apps Market, Research Framework
FIGURE 4. Global Lifestyle Diseases Apps Market, Data Triangulation
FIGURE 5. Global Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Lifestyle Diseases Apps Market Size, by Functionality, 2025 vs 2032 (%)
FIGURE 7. Global Lifestyle Diseases Apps Market Size, by Functionality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Lifestyle Diseases Apps Market Size, by Indications, 2025 vs 2032 (%)
FIGURE 9. Global Lifestyle Diseases Apps Market Size, by Indications, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Lifestyle Diseases Apps Market Size, by Type, 2025 vs 2032 (%)
FIGURE 11. Global Lifestyle Diseases Apps Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Lifestyle Diseases Apps Market Size, by User, 2025 vs 2032 (%)
FIGURE 13. Global Lifestyle Diseases Apps Market Size, by User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Lifestyle Diseases Apps Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 15. Global Lifestyle Diseases Apps Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Lifestyle Diseases Apps Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Lifestyle Diseases Apps Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Lifestyle Diseases Apps Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Lifestyle Diseases Apps Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Lifestyle Diseases Apps Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Lifestyle Diseases Apps Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Lifestyle Diseases Apps Market Segmentation & Coverage
TABLE 2. Global Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 3. Global Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 4. Global Clinical Decision Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Clinical Decision Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Clinical Decision Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Monitoring & Follow-Up Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Monitoring & Follow-Up Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Monitoring & Follow-Up Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Patient Education & Empowerment Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Patient Education & Empowerment Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Patient Education & Empowerment Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Treatment & Medication Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Treatment & Medication Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Treatment & Medication Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 17. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cardiovascular Conditions Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cardiovascular Conditions Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cardiovascular Conditions Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 33. Global Mobile Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Mobile Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Mobile Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Android Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Android Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Android Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global iOS Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global iOS Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global iOS Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Web-Based Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Web-Based Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Web-Based Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 46. Global Healthcare Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Healthcare Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Healthcare Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Rehabilitation Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Rehabilitation Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Rehabilitation Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 59. Global On-cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global On-cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global On-cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global On-premises Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global On-premises Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global On-premises Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 74. North America Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. North America Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 76. North America Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 77. North America Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 78. North America Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 79. North America Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 80. North America Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 81. North America Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 82. Latin America Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 84. Latin America Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 85. Latin America Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 86. Latin America Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 87. Latin America Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 88. Latin America Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 89. Latin America Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 90. Europe Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 92. Europe Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 93. Europe Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 94. Europe Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 95. Europe Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 96. Europe Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 97. Europe Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 98. Middle East Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Middle East Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 100. Middle East Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 101. Middle East Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 102. Middle East Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 103. Middle East Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 104. Middle East Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 105. Middle East Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 106. Africa Lifestyle Diseases Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Africa Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 108. Africa Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 109. Africa Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 110. Africa Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 111. Africa Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 112. Africa Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 113. Africa Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 114. Global Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 117. ASEAN Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 118. ASEAN Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 119. ASEAN Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 120. ASEAN Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 121. ASEAN Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 122. ASEAN Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 123. GCC Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. GCC Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 125. GCC Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 126. GCC Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 127. GCC Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 128. GCC Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 129. GCC Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 130. GCC Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 131. European Union Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. European Union Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 133. European Union Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 134. European Union Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 135. European Union Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 136. European Union Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 137. European Union Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 138. European Union Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 139. BRICS Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. BRICS Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 141. BRICS Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 142. BRICS Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 143. BRICS Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 144. BRICS Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 145. BRICS Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 146. BRICS Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 147. G7 Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. G7 Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 149. G7 Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 150. G7 Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 151. G7 Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 152. G7 Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 153. G7 Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 154. G7 Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 155. NATO Lifestyle Diseases Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. NATO Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 157. NATO Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 158. NATO Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 159. NATO Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 160. NATO Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 161. NATO Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 162. NATO Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 163. Global Lifestyle Diseases Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. United States Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 165. United States Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 166. United States Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 167. United States Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 168. United States Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 169. United States Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 170. United States Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 171. United States Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 172. Canada Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 173. Canada Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 174. Canada Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 175. Canada Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 176. Canada Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 177. Canada Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 178. Canada Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 179. Canada Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 180. Mexico Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 181. Mexico Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 182. Mexico Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 183. Mexico Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 184. Mexico Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 185. Mexico Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 186. Mexico Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 187. Mexico Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 188. Brazil Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 189. Brazil Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 190. Brazil Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 191. Brazil Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 192. Brazil Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 193. Brazil Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 194. Brazil Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 195. Brazil Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 196. United Kingdom Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 197. United Kingdom Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 198. United Kingdom Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 199. United Kingdom Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 200. United Kingdom Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 201. United Kingdom Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 202. United Kingdom Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 203. United Kingdom Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 204. Germany Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 205. Germany Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 206. Germany Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 207. Germany Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 208. Germany Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 209. Germany Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 210. Germany Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 211. Germany Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 212. France Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 213. France Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 214. France Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 215. France Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 216. France Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 217. France Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 218. France Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 219. France Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 220. Russia Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 221. Russia Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 222. Russia Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 223. Russia Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 224. Russia Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 225. Russia Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 226. Russia Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 227. Russia Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 228. Italy Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 229. Italy Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 230. Italy Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 231. Italy Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 232. Italy Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 233. Italy Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 234. Italy Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 235. Italy Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 236. Spain Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 237. Spain Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 238. Spain Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 239. Spain Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 240. Spain Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 241. Spain Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 242. Spain Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 243. Spain Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 244. China Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 245. China Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 246. China Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 247. China Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 248. China Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 249. China Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 250. China Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 251. China Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 252. India Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 253. India Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 254. India Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 255. India Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 256. India Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 257. India Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 258. India Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 259. India Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 260. Japan Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 261. Japan Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 262. Japan Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 263. Japan Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 264. Japan Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 265. Japan Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 266. Japan Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 267. Japan Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 268. Australia Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 269. Australia Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 270. Australia Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 271. Australia Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 272. Australia Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 273. Australia Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 274. Australia Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 275. Australia Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 276. South Korea Lifestyle Diseases Apps Market Size, 2017-2032 (USD Million)
TABLE 277. South Korea Lifestyle Diseases Apps Market Size, by Functionality, 2017-2032 (USD Million)
TABLE 278. South Korea Lifestyle Diseases Apps Market Size, by Indications, 2017-2032 (USD Million)
TABLE 279. South Korea Lifestyle Diseases Apps Market Size, by Type, 2017-2032 (USD Million)
TABLE 280. South Korea Lifestyle Diseases Apps Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 281. South Korea Lifestyle Diseases Apps Market Size, by User, 2017-2032 (USD Million)
TABLE 282. South Korea Lifestyle Diseases Apps Market Size, by Healthcare Providers, 2017-2032 (USD Million)
TABLE 283. South Korea Lifestyle Diseases Apps Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 284. Global Lifestyle Diseases Apps Market Share, by Key Player, 2025
TABLE 285. Global Lifestyle Diseases Apps Market, Key Experts

Companies Mentioned

  • Apple Inc.
  • BetterMe Inc.
  • Buoy Health, Inc.
  • Calm.com, Inc.
  • Cerebral, Inc.
  • ClassPass Inc.
  • Fitbit, Inc.
  • FitOn Inc.
  • Fooducate, Ltd.
  • Google LLC
  • Headspace Inc.
  • JEFIT Inc.
  • Johnson & Johnson
  • Kaiser Permanente
  • Kilo Health
  • Lark Technologies, Inc.
  • Lifesum AB
  • MapMyFitness, Inc.
  • Mindbody, Inc.
  • MyFitnessPal, Inc.
  • Noom, Inc.
  • Omada Health, Inc.
  • Peloton Interactive, Inc.
  • Samsung Electronics Co., Ltd.
  • Teladoc Health, Inc.
  • UnitedHealth Group
  • Virta Health Corp.
  • Weight Watchers International, Inc.
  • WW International, Inc.
  • Yazio GmbH

Related Topics

Related Reports

Preventive Healthcare Technologies & Services Market - Global Forecast 2026-2032 - Product Image

Preventive Healthcare Technologies & Services Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Mobile Application Market - Global Forecast 2026-2032 - Product Image

Mobile Application Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Lifestyle Diseases Apps - Global Strategic Business Report - Product Image

Lifestyle Diseases Apps - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Diet and Nutrition Apps - Global Strategic Business Report - Product Image

Diet and Nutrition Apps - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Lifestyle Diseases Apps Market Report 2026 - Product Image

Lifestyle Diseases Apps Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.